Mao Shuli, Bouygues Martin, Welch Christopher, Biba Mirlinda, Chilenski Jen, Schinazi Raymond F, Liotta Dennis C
Department of Chemistry, Emory University, 403 Cherry Logan Emerson Hall, 1521 Dickey Drive, Atlanta, GA 30322, USA.
Bioorg Med Chem Lett. 2004 Oct 4;14(19):4991-4. doi: 10.1016/j.bmcl.2004.07.016.
The beta-D-enantiomer of FDOC (2',3'-dideoxy-5-fluoro-oxacytidine) exhibits potent anti-HIV-1 activity. It was obtained in optically pure form by employing a tandem kinetic resolution/chiral salt crystallization protocol. In addition, conditions were developed that allowed the unwanted butyrate ester of the L-enantiomer of FDOC to be racemized. This material could then be recycled in future resolutions.
FDOC(2',3'-二脱氧-5-氟氧杂胞苷)的β-D-对映体具有强大的抗HIV-1活性。通过采用串联动力学拆分/手性盐结晶方案,以光学纯形式获得了该对映体。此外,还开发了一些条件,使FDOC的L-对映体中不需要的丁酸酯能够外消旋化。然后,这种物质可以在未来的拆分中循环利用。